Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
10
self-reported 2–10 band
Founded
2016
10 years
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
None on record
Company type
Public Company
self-reported
Legal entity
1 brand → 1 confirmed entity
AMPLIA THERAPEUTICS LIMITED
ABN16165160841
Legal entities
Show as table · Amplia Therapeutics Limited: 1 registry entity
| AMPLIA THERAPEUTICS LIMITED | ABN 16165160841 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Amplia Therapeutics Limited (ASX: ATX; OTCQB: INNMF), a pharmaceutical company based in Melbourne, Australia, focuses on development of focal adhesion kinase (FAK) inhibitors for the treatment of cancer and chronic fibrotic diseases.
The company's lead product is narmafotinib (AMP945), a best-in-class inhibitor of FAK, currently undergoing clinical trials in advanced pancreatic cancer. Data from the Phase 1b/2a ACCENT trial run in Australia and Korea has been very positive and a new clinical trial is now opening in the US and Australia under an open IND.
Additional opportunities in other cancers such as ovarian cancer, and in fibrotic diseases such as idiopathic pulmonary fibrosis, are also being explored based on promising preclinical data.
Narmafotinib has Orphan Drug Designation and Fast-Track Designation from the US FDA for pancreatic cancer.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AU90 William St; Level 5; Melbourne, Victoria 3000Primary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
3 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entity operates under Amplia Therapeutics Limited?
One Victoria entity on the ABR: AMPLIA THERAPEUTICS LIMITED (ABN 16 165 160 841), high confidence.
How many people work at Amplia Therapeutics Limited?
10 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Where does Amplia Therapeutics Limited have offices?
One address on record, Australia only. Primary: 90 William St, Level 5, Melbourne, Victoria 3000.
Has Amplia Therapeutics Limited raised funding?
None linked to this brand.
Which companies are listed alongside Amplia Therapeutics Limited?
16 profiles list Amplia Therapeutics Limited as a peer — 92nd percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. Aculeus Therapeutics and Canthera Discovery (Canthera Discovery Ltd) list it back.